TIP24-199: Rhenium (Re-186) Obisbemeda {Re-186-Nanoliposome (186RNL)} in Leptomeningeal Metastases [LM] Phase 1/2A Dose Escalation Trial: Update of Initial Safety and Feasibility Through Cohorts 1-4. (PubMed, J Natl Compr Canc Netw) - Apr 6, 2024 - No abstract available
Journal • P1/2 data • Oncology
|
|
Ande Bao; Andrew Brenner; Jeffrey Weinberg; Joel Michalek; John Floyd; Marc Hedrick; Melissa Moore; Michael Youssef; Norman LaFrance; Priya Kumthekar; Toral Patel; William Phillips
|